AIDS 2022: the agency takes part in the conference dedicated to HIV

27 July 2022

The ANRS | Emerging Infectious Diseases is participating in the International AIDS Society (IAS) AIDS Conference in Montreal from July 29 to August 2, 2022. In addition to partnering with the event, the agency is organizing a symposium, awards six prizes to young researchers and having the work it supports presented during the scientific sessions.


The AIDS conference, organized every two years by the IAS, brings together thousands of researchers from all continents to assess progress made on HIV/AIDS. This year, for the 24th edition, the theme is "re-engage and follow the science". The event is held in Montreal and in virtual format. The ANRS | Emerging Infectious Diseases is committed to carry on its involvement in this major international event.

1 symposium

The agency is organizing a satellite symposium on community-based research, bringing together international experts, researchers and association representatives.

  • Friday, July 29th, 2022 from 1:00 p.m. to 2:30 p.m. (Montreal time) / from 7:00 p.m. to 8:30 p.m. (Paris time) - Room 517c / Channel 5

Find out more about the program:

A thematic folder is availaible here:

The replay will be availaible following the event.

1 stand

The France stand highlights the country’s commitment to the fight against HIV. The CRIPS Île-de-France, the Ministry of Europe and Foreign Affairs, the Ministry of Health and Prevention, the DGS, Expertise France and the ANRS | Emerging Infectious Diseases are the funders.

Several meetings are planned. Among them, a meeting between the Ministry of Europe and Foreign Affairs, the GHA, Unitaid and the agency will be held on the theme "universal access to health innovations / health a global good?" from 3:00 to 4:00 p.m. (Montreal time), on July 31.
A discussion on "3x95: what solutions to reach the first 95?" is also scheduled for August 1 from 3:00 to 4:00 p.m. (Montreal time).

Meet us in the exhibition area, booth 1010 (level 2).

5 interventions

Pr Yazdan Yazdanpanah is participating in two sessions:

  • "How does implementation science affect HIV policy and vice versa?" July 29th between 11:45 a.m. to 12:45 a.m. (Montreal time) / 5:45 p.m. to 6:45 (Paris time) – Room 510 or channel 8:
  • The symposium : "Treatment Optimisation: Lessons from ADVANCE, DolPHIN 2 and NAMSAL trials" with Mireille MPoudi NGole-Etame from the ANRS partner site in Cameroon, July 30, 8:00-9:00 a.m. (Montreal time) / 2:00-3:00 p.m. (Paris time) – room 517b or channel 4:

Jacqueline Capeau will speak at the symposium "Metabolic consequences of new classes of ART" on July 30 from 10:30 to 11:30 a.m. (Montreal time) / 4:30 to 5:30 p.m. (Paris time) – Room 510 or channel 8:

Asier Sáez-Cirión (Institut Pasteur), co-coordinator of the ANRS RHIVIERA consortium, will participate in the symposium "Combinations to reprogram CD8+ T cells" on July 31 from 2:15 to 3:15 p.m. (Montreal time) / 8:15 to 9:45 p.m. (Paris time) – Room 517d or channel 2:

Sharon Lewin, Director of the Peter Doherty Institute for Infection and Immunity and Chair of the Agency's Scientific Advisory Board, will speak at the closing session of the conference on August 2 from 4:45-5:30 p.m. (Montreal time) / 10:45-11:30 p.m. (Paris time) – Room 220 d/e channel 1:

6 awards for young researchers

The six IAS/ANRS Lange/van Tongeren reward young researchers whose work on HIV are innovative, original and of high quality in each of the event's scientific categories. Winners receive a prize of US$2,000, awarded jointly by the IAS and the agency.

21 selected abstracts

This year again, research supported by the agency has been selected by the IAS to be presented during the scientific sessions.

Presenter Type of présentation Title Link to the program
Mireille Mpoudi-Etame oral abstract Dolutegravir versus Efavirenz-400 as first-line ART in Cameroon: Week 192 data of NAMSAL trial Lien
  • 30 juillet 10:00-11:30 a.m. (Montreal time) / 4:30-5:30 (Paris time) - Room 517/b or channel 4
Basma Abdi e-poster Seroprevalence of SARS-CoV-2 infection and evolution of humoral response in PLWHIV Link
Maryam Bendoumou e-poster Role of UHRF1 in HIV-1 transcriptional regulation Link
Alexandra Bitty-Anderson e-poster Low awareness of pre-exposure prophylaxis among female sex workers in Togo Link
Lucy Kundura Poster exhibition Low frequency of activated T cells in people living with HIV, aviremic under treatment, and presenting neurocognitive disorders Link
Pierre Debeaudrap e-poster Evaluation of screening algorithms based on HPV testing with partial genotyping for the prevention of cervical cancer among HIV-infected women in resource-limited countries: results of the ANRS 12375 study Link
August Eubanks e-poster Socio-behavioral correlates of PrEP uptake and correct PrEP adherence in men who have sex with men in West Africa (CohMSM-PrEP ' ANRS12369 ' Expertise France) Link
Inès Dourado e-poster SARS-CoV-2 antibodies prevalence among sexual and gender minorities youth in Brazil Link
Marion Fiorentino e-poster
Factors associated with HIV transmission risk from men who have sex with men to women in West Africa (CohMSM ANRS 12324-Expertise France)
Vincent Cantaloube-Ferrieu e-poster Barriers that limit cell-free HIV-1 entry into macrophages are overcome after cell-cell fusion with infected T cells Link
Marcellin Nouaman e-poster Prevalence and incidence of sexually transmitted infections in a cohort of female sex workers in San Pedro, Côte d'Ivoire (ANRS 12381 PRINCESSE) Link
Joseph Larmarange e-poster Delays to PrEP initiation among female sex workers in Côte d’Ivoire (ANRS 12381 PRINCESSE project) Link
Celso Khosa e-poster Incidence and risk factors for liver enzyme elevation in HIV-1 infected patients treated for tuberculosis: a secondary analysis of the multi-country ANRS 12300 REFLATE TB2 trial Link
Dominique Costagliola e-poster Projection of age of people living with HIV and time since ART initiation in high-income countries in 2030: estimates for France Link
Delphine Planas e-poster Side-by-side comparison of SARS-CoV-2 neutralizing antibody responses after various COVID-19 vaccine regimens Link
Perrine Roux e-poster Characteristics of chemsexers in France during the COVID-19 pandemic: results from the ERAS 2021 national online survey Link
Perrine Roux e-poster The positive impact of drug consumption rooms on HIV/HCV risk practices among people who inject drugs: results from the COSINUS cohort study Link
Carine Van Lint e-poster Role of the polgene enhancer in HIV-1 transcription and replication in myeloid infected cells


Leslie Alcouffe e-poster Sexual health of migrant women attending French Red Cross Health Prevention Centers in French Guiana, in 2021 Link
Nicolas Vignier e-poster

Knowledge of HIV pre-exposure prophylaxis and antiretrovirals preventive potential of among migrant women in French Guiana


Diogo Gama Caetano e-poster Alterations in B lymphocyte subsets in virologically suppressed HIV-positive individuals did not impact 17DD yellow fever vaccine immunogenicity - ANRS 12403 Link



More information:

AIDS 2022 :
Communication and Scientific Information Department: